CLINICAL_TRIALS
trial_result
· 2019-10-16
Clinical Trial Update: A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer [Phase 3]
Summary
A randomized Phase III trial comparing POF with SOX/CAPOX/FOLFOX as postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fujian Cancer Hospital | Conditions: Gastric Cancer Stage III | Phase 3 | Status: UNKNOWN